Production (Stage)
Firefly Neuroscience, Inc.
AIFF
$3.46
$0.102.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -72.48% | -78.31% | -84.55% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -72.48% | -78.31% | -84.55% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -72.48% | -78.31% | -84.55% | -- | -- |
| SG&A Expenses | 158.34% | 158.69% | 273.15% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 149.35% | 159.73% | 188.47% | -- | -- |
| Operating Income | -180.26% | -198.25% | -243.33% | -- | -- |
| Income Before Tax | -602.18% | -302.85% | -218.05% | -- | -- |
| Income Tax Expenses | 100.00% | 100.00% | -- | -- | -- |
| Earnings from Continuing Operations | -602.02% | -302.77% | -218.10% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -602.02% | -302.77% | -218.10% | -- | -- |
| EBIT | -180.26% | -198.25% | -243.33% | -- | -- |
| EBITDA | -301.55% | -163.67% | -198.48% | -- | -- |
| EPS Basic | -304.35% | -152.09% | -98.67% | -- | -- |
| Normalized Basic EPS | -226.03% | -132.18% | -78.54% | -- | -- |
| EPS Diluted | -304.35% | -152.09% | -98.67% | -- | -- |
| Normalized Diluted EPS | -226.03% | -132.18% | -78.54% | -- | -- |
| Average Basic Shares Outstanding | 58.23% | 16.78% | 10.55% | -- | -- |
| Average Diluted Shares Outstanding | 58.23% | 16.78% | 10.55% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |